Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by Thetrading999on Jun 27, 2017 7:31pm
206 Views
Post# 26411375

Lifestyle Delivery closes $1-million private placement

Lifestyle Delivery closes $1-million private placement

 

Lifestyle Delivery Systems Inc (C:LDS) 
Shares Issued 57,142,130
Last Close 6/27/2017 $0.62
Tuesday June 27 2017 - News Release

Mr. Brad Eckenweiler reports

LIFESTYLE DELIVERY SYSTEMS ANNOUNCES COMPLETION OF NON-BROKERED PRIVATE PLACEMENT FINANCING

Lifestyle Delivery Systems Inc. has closed a non-brokered private placement financing of a total of 2,019,540 units at a price of 50 cents per unit, for total gross proceeds of $1,009,770. Due to strong investor demand, the financing was oversubscribed.

Each Unit sold in the Financing consisted of one common share of the Company (each a "Unit Share") and one common share purchase warrant (each a "Warrant") entitling the holder to purchase one additional common share (a "Warrant Share") at a price of $0.75 per Warrant Share for a period ending one year from the date of issuance. The Company may accelerate the expiration date of the Warrants if the daily volume weighted average share price of the Company's common shares on the Canadian Securities Exchange (or such other stock exchange as the Company's common shares are then trading on) is equal to or greater than Cdn$1.50 for 10 consecutive trading days.

In connection with the Financing, the Company has agreed to pay cash commissions of Cdn$26,775 and to issue 53,550 finder's warrants (the "Finder's Warrant"). Each Finder's Warrant is exercisable for one Unit at the Issue Price for a period of 12 months from closing of the Offering.

The securities issued under the Offering will be subject to a hold period expiring on October 28, 2017 pursuant to applicable Canadian securities laws.

About Lifestyle Delivery Systems Inc.

The Company's technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking, but also a new way to accurately meter the dosage and assure the purity of the product. In addition, with the entering into its management services agreements with NHMC, Inc. and CSPA Group, Inc., the Company has begun its foray into being directly involved in the growing of medicinal ingredients for, and the manufacturing of, its products. From seed to sale, the Company's products and ingredients will be tested for quality and composition throughout the formulation and production processes, resulting in a delivery system that is safe, consistent and effective.

We seek Safe Harbor.

© 2017 Canjex Publishing Ltd.

Bullboard Posts